Chlorproguanil/dapsone (sold commercially as Lapdap) was a fixed dose antimalarial combination containing chlorproguanil and dapsone, which act synergistically against malaria.
Chlorproguanil/dapsone (sold under the brand name Lapdap), is a combined medication used to treat malaria. It contains two active ingredients: chlorproguanil and dapsone, which work together effectively against the disease.